Expert: Circulating tumor DNA is a “hidden link” for monitoring colorectal and other cancers
In an interview with Pharmacy Times Bruce Feinberg, DO, vice president and chief physician at Cardinal Health Specialty Solutions, discussed the use of circulating tumor DNA (ctDNA), its current use in colorectal cancer, and how it could be used in the future at the annual meeting of the American Society for Clinical Oncology (ASCO) 2022. …